TAM
LKFT

Tocqueville Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Tocqueville Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,500
Closed -$534K – 748
2019
Q3 		$534K Buy
+3,500
New +$574K 0.01% 547

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Tocqueville Asset Management's LKFT Position: Q4 2019 in Review

Tocqueville Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2019, closing a stake of 3,500 shares — an estimated $534K sold.

Tocqueville Asset Management first reported a position in LKFT in Q3 2019 and held it in 1 quarter. The position peaked at $534K in Q3 2019. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.

  • Tocqueville Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 3,500 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $534K.
  • Tocqueville Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and held it in 1 quarter.
  • Tocqueville Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $534K in Q3 2019.
  • 137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.

Based on Tocqueville Asset Management's 13F filing for Q4 2019, filed 14 Jan 2020.